Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Fitting With or Without Fine Structure Coding

NCT ID: NCT05754918

Last Updated: 2025-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-15

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Brief Summary:

Main objective:

Comparison of a tonotopy based fitting strategy (TFS) with fine structure coding to a tonotopy based fitting strategy without fine structure coding (TnoFS) for speech perception in noise.

Secondary objectives:

Comparison of TFS to TnoFS for the perception of musical elements (contour test).

Comparison of TFS to TnoFS for speech perception in quiet

Comparison of TFS to TnoFS for the qualitative preference for the listening of musical pieces.

Comparison of TFS to TnoFS for the melodic recognition

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction: Cochlear implantation allows the rehabilitation of profound bilateral deafness, restoring speech perception and verbal communication when the traditional hearing aid no longer provides satisfactory hearing gain (Nimmons et al.).

A cochlear implant includes an electrode array and its functioning is based on the principle of cochlear tonotopy: each electrode encodes a frequency spectrum according to its position in the cochlea (high frequencies are assigned to the basal electrodes and low frequencies to the apical electrodes). The cochlear implant thus breaks down the frequency spectrum into a number of frequency bands via bandpass filters corresponding to the number of electrodes in the implant. During the fitting these bands can be modified by the audiologist.

The fitting software developed by the manufacturers proposed a default fitting with a lower limit between 100 and 250 Hz according to the brands and an upper limit of about 8500 Hz. The frequency bands assigned to each electrode follow a logarithmic scale with the high frequencies for the basal electrodes and the low frequencies for the apical electrodes. This distribution takes into account the number of active electrodes but does not take into account the anatomy and the natural cochlear tonotopy specific to each patient.

Several studies have analyzed the anatomical variations of the cochlear dimensions: size of the cochlea and the ratio between the contact surfaces of the electrodes with the cochlea are variable from one patient to another (Stakhovskaya O et al., P. Pelliccia et al.).

The insertion depth during surgery is also variable due to parameters related to the patients as well as to the operator, which seems to impact the understanding of speech in noise (Deep electrode insertion and sound coding in cochlear implants - Ingeborg Hochmair et al.).

Mathematical algorithms have recently been developed to estimate the cochlear tonotopy of each patient from a CT scan assessment (Jiam et al., Sridhar et al.). CT imaging of the implanted ear combined with 3D reconstruction software, provides cochlear length measurements (Cochlear length determination using Cone Beam Computed Tomography in a clinical setting - Würfel et al .). Using this approach it is possible to measure the position of each electrode relative to the cochlear apex. These measurements are applied to the modified Greenwood equation to obtain the tonotopic frequency for each electrode and to determine for each patient a fitting based on the tonotopy of each electrode.

Conventional stimulation strategies in cochlear implants (e.g. advanced combination encoder (ACE), continuous interleaved sampling (CIS)) use the place of the electrode to code the frequency by sending low frequency information on the apical electrodes and high frequency information on the basal electrodes. The stimulation rate of the electrodes is constant. The pitch is only partially transmitted by these conventional strategies which would explain the poor results of cochlear implants in the perception of music. In the FineHearing strategy of the MED-EL implant, the rate of stimulation on the low-frequency electrodes is related to the frequency of the sound and makes it possible to code the frequency information temporally.

Rader \& al. 2016 have studied the contribution of adding to the tonotopic coding of the frequency (classical strategy) a temporal coding of the information by varying the stimulation rate. The results obtained show that providing this frequency information by time coding makes it possible to obtain perceived pitch much closer to the expected pitch (of normal-hearing) and less variability, especially at low frequencies. With fixed stimulation rate (classical strategy) low frequencies are poorly coded, whereas with the variable stimulation rate they are better coded. In addition, Landsberger et al. \[2018\] studied in six subjects with a MED-EL implant the perception of a temporal coding according to the position of the electrodes with a long insertion: middle or apical position. The results seem to show that the temporal coding of the frequency would be more reliable than the spatial coding (related to the position of the electrode) at the apex, and the reverse on the electrodes in the middle position. Studies have shown that the FineHearing strategy can provide benefits over the classic High-Definition Continuous Interleaved Sampling (HDCIS) strategy in tasks involving the fundamental F0 such as speech recognition in noise (after a certain learning time) \[Kleine Punte \& al. 2014 ; Vermeire \& al. 2010\], the perception of music \[Roy \& al. 2015 ; Roy \& al. 2016\] or the perceived quality of pitch \[Müller \& al. 2012\].

MED-EL's FineHearing coding strategy with a tonotopic-based fitting could therefore allow better transmission of pitch and in particular improve the speech recognition in noise compared to the same tonotopic-based fitting without FineHearing coding.

Main objective:

Comparison of a tonotopy based fitting strategy (TFS) with fine structure coding to a tonotopy based fitting strategy without fine structure coding (TnoFS) for speech perception in noise.

Secondary objectives:

Comparison of TFS to TnoFS for the perception of musical elements (contour test).

Comparison of TFS to TnoFS for speech perception in quiet

Comparison of TFS to TnoFS for the qualitative preference for the listening of musical pieces.

Comparison of TFS to TnoFS for the melodic recognition

Plan of the study:

It is a prospective open monocentric randomized crossover study: measures will be done on the patient at 6 weeks and 12 weeks post-activation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sensorineural Hearing Loss, Bilateral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Two arms A and B:

Arm A: patient's fitting with tonotopy-based fitting without fine structure coding (TnoFS) --\> 6 weeks use --\> tests and patient's fitting with tonotopy-based fitting with fine structure coding (TFS) --\> 6 weeks use --\> tests; Arm B: patient's fitting with TFS --\> 6 weeks use --\> tests and patient's fitting with TnoFS --\> 6 weeks use --\> tests
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators
Double blind study: the patient and the investigator don't know the fitting.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TnoFS then TFS

Cochlear Implant with TnoFS first during 6 weeks then with TFS during 6 weeks

Group Type ACTIVE_COMPARATOR

TnoFs then TFS (Cochlear implant)

Intervention Type DEVICE

Cochlear implant with tonotopy-based fitting without fine structure coding then with fine structure coding

TFS then TnoFS

Cochlear Implant with TFS first during 6 weeks then with TnoFS during 6 weeks

Group Type ACTIVE_COMPARATOR

TFS then TnoFS (Cochlear implant)

Intervention Type DEVICE

Cochlear implant with tonotopy-based fitting with fine structure coding then without fine structure coding

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TnoFs then TFS (Cochlear implant)

Cochlear implant with tonotopy-based fitting without fine structure coding then with fine structure coding

Intervention Type DEVICE

TFS then TnoFS (Cochlear implant)

Cochlear implant with tonotopy-based fitting with fine structure coding then without fine structure coding

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient (\>= 18 years old) speaking French
* Patient who fulfils the criteria for cochlear implantation
* Total hearing loss for less than 5 years

Exclusion Criteria

* retro-cochlear pathology: auditory neuropathy, vestibular schwannoma
* patient with residual hearing \< 60 dB HL at 250 Hz and \< 80 dB HL at 500 Hz
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MED-EL Elektromedizinische Geräte GesmbH

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gwenaelle Creff, Dr

Role: PRINCIPAL_INVESTIGATOR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Rennes

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MED_EL_COFRET_Rennes_study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Pulses on Loudness
NCT04010721 COMPLETED NA
Optimization of Music Compression
NCT02373228 COMPLETED NA